161.86
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics Incorporated (DGX): A Bull Case Theory - Yahoo
Examining the Future: Quest Diagnostics's Earnings Outlook - Nasdaq
Drug Abuse Testing Market Forecast Report and Company - GlobeNewswire
Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo
Quest Diagnostics Declares Quarterly Cash Dividend - Quantisnow
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.
Peering Into Quest Diagnostics's Recent Short Interest - Benzinga
Price Over Earnings Overview: Quest Diagnostics - Benzinga
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings - MSN
Quest Diagnostics price target raised to $198 from $190 at BofA - Yahoo Finance
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Quest Diagnostics (DGX): Price Target Increased to $198 by BofA Analyst | DGX Stock News - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest introduces blood test to confirm amyloid brain pathology in Alzheimer’s - Medical Device Network
Quest Diagnostics (NYSE:DGX) Unveils New Alzheimer's Blood Test With Promising Predictive Accuracy - Yahoo Finance
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease - PR Newswire
Revolutionary Blood Test Transforms Alzheimer's Diagnosis: Quest's New 91%-Accurate Solution - Stock Titan
Here's What to Expect From Quest Diagnostics’ Next Earnings Report - MSN
Quest Diagnostics : To Speak At The 38th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Compensation Up For Quest Diagnostics GC After Earlier Dip - Law360
Quest Diagnostics (DGX) Shares Cross 2% Yield Mark - Nasdaq
Here's What To Expect From Quest Diagnostics’ Next Earnings Report - Barchart.com
Lobbying Update: $80,000 of QUEST DIAGNOSTICS INCORPORATED lobbying was just disclosed - Nasdaq
Quest Diagnostics CEO sells $6.6 million in stock By Investing.com - Investing.com South Africa
Quest Diagnostics CEO sells $6.6 million in stock - Investing.com
Quest Diagnostics SVP Karthik sells $434,350 in stock By Investing.com - Investing.com Canada
Quest Diagnostics SVP Karthik sells $434,350 in stock - Investing.com
Quest Diagnostics' (NYSE:DGX) Dividend Will Be Increased To $0.80 - Yahoo Finance
Ex-Dividend Reminder: Quest Diagnostics, Preferred Bank and Erie Indemnity - Nasdaq
Redburn Atlantic Initiates Quest Diagnostics at Buy With $195 Price Target - MarketScreener
Quest Diagnostics Incorporated (NYSE:DGX) Passed Our Checks, And It's About To Pay A US$0.80 Dividend - Yahoo
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Redburn Atlantic initiated coverage on Quest Diagnostics with a new price target - Quantisnow
Quest Revolutionizes Cervical Cancer Screening with New Self-Collection Test - Stock Titan
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 - Nasdaq
Quest Health Review 2025: Services, Pricing, and Reliability - Healthline
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Is Quest Diagnostics Stock Outperforming the S&P 500? - MSN
SVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 162 shares, decreasing direct ownership by 0.77% to 20,988 units (SEC Form 4) - Quantisnow
Is Quest Diagnostics Stock Worth Holding Onto Right Now? - MSN
Nephron Research Downgrades Quest Diagnostics to Hold From Buy, $184 Price Target - Marketscreener.com
Is Quest Diagnostics Stock Outperforming The S&P 500? - Barchart.com
Truist maintains hold on Quest Diagnostics stock, $182 target By Investing.com - Investing.com Australia
Quest Diagnostics (DGX) and Google Cloud to Transform Healthcare Data with AI - Insider Monkey
DGX Stock Set to Benefit From New Google Cloud Partnership - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):